22 results
424B5
ZYME
Zymeworks Inc.
3 May 24
Prospectus supplement for primary offering
4:17pm
of these products will depend on reimbursement policies and may be affected by future healthcare
S-20
reform measures. Government authorities and third … products that we develop, due to the trend toward managed healthcare, the increasing influence of health maintenance organizations and additional
424B5
ZYME
Zymeworks Inc.
3 May 24
Prospectus supplement for primary offering
4:11pm
regulatory authorities, market acceptance and sales of these products will depend on reimbursement policies and may be affected by future healthcare reform … pressures in connection with the sale of any products that we develop, due to the trend toward managed healthcare, the increasing influence of health
8-K
ZYME
Zymeworks Inc.
1 Apr 24
Departure of Directors or Certain Officers
9:00am
, pharmaceutical and healthcare sectors. Mr. Galbraith received his B.Comm. from the University of British Columbia.
The compensatory and other material terms
8-K
EX-99.1
ofm5l90
4 Jan 24
Zymeworks Outlines Strategic Priorities and Outlook for 2024 and 2025
6:31am
8-K
64q187y0ki1tam cyg5r
18 May 23
Zymeworks Announces Departure of Neil Klompas, President and Chief Operating Officer
8:40am
8-K
EX-10.1
87zja
16 May 23
Entry into a Material Definitive Agreement
8:30am
424B5
6vz 8svgnu
8 May 23
Prospectus supplement for primary offering
5:19pm
424B5
iqf0icyd
8 May 23
Prospectus supplement for primary offering
5:18pm
DEF 14A
5hkcmnn11v1pmmvs9awp
25 Nov 22
Definitive proxy
6:16am
424B5
lh6 hcdsumauqzau0
9 Nov 22
Prospectus supplement for primary offering
4:29pm
10-Q
fghhmwh06lmuv
8 Nov 22
Quarterly report
4:09pm
424B5
k7w3g 0h64jzexpy
21 Oct 22
Prospectus supplement for primary offering
4:16pm
424B5
f9chnkf z1tfaa64w
13 Oct 22
Prospectus supplement for primary offering
4:56pm